Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Gadolinium
Drug ID BADD_D00989
Description Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease.
Indications and Usage
Marketing Status Not Available
ATC Code Not Available
DrugBank ID DB12091
KEGG ID Not Available
MeSH ID D005682
PubChem ID 23982
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms Gadolinium
Chemical Information
Molecular Formula Gd
CAS Registry Number 7440-54-2
SMILES [Gd]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Flatulence07.01.04.002--
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Glioma17.20.01.004; 16.30.01.004--Not Available
Haemoptysis24.07.01.006; 22.02.03.004; 02.01.02.006--Not Available
Hallucination19.10.02.002--
Headache17.14.01.001--
Hyperacusis17.04.03.003; 04.02.02.001--Not Available
Hypercalcaemia14.04.01.003; 05.04.01.002--
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hypoaesthesia17.02.06.023--Not Available
Hypoglycaemia05.06.03.001; 14.06.03.001--
Hyponatraemia14.05.04.002--
Hypotension24.06.03.002--
Immune system disorder10.02.01.001--Not Available
Increased appetite14.03.01.003; 08.01.09.027--Not Available
Injection site bruising23.03.11.015; 12.07.03.042; 08.02.03.042; 24.07.06.017--Not Available
Injection site haemorrhage24.07.01.010; 12.07.03.005; 08.02.03.005--Not Available
Injection site inflammation12.07.03.009; 08.02.03.008--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Injection site reaction12.07.03.015; 08.02.03.014--
Lacrimation increased06.08.02.004--
Laryngeal oedema23.04.01.005; 22.04.02.001; 10.01.05.003--
Laryngospasm22.04.02.002--
Lip swelling07.05.04.005; 23.04.01.007; 10.01.05.005--Not Available
The 3th Page    First    Pre   3 4 5 6    Next   Last    Total 6 Pages